GlaxoSmith Kline Mission: to improve the quality of life by enabling people to do more‚ feel better and live longer 1. Customer/Marketing: People of all ages who want an active‚ better and long life. 2. Product or Service: Not specified but can be assumed as any product that can extend people’s life and make it better and increase their activity. 3. Market: Not specified but can be assumed to be the entire world. 4. Technology: Not specified. 5. Concern for Survival: Not specified. 6. Company Philosophy:
Premium Customer Rate of return Life
The title of the research study is Student’s Understanding and Practices Regarding Communicative Language Teaching (CLT) in Malaysian Secondary schools. This research study was conducted to interrogate about communicative language teaching in Malaysian secondary schools. The main purpose of this research study was to know how far the communicative language teaching was understood and how does it implemented in Malaysian secondary school. These elements was identified based on the student’s point
Premium Communicative language teaching Communicative language teaching Teaching English as a foreign language
from the simple / easy ones to the more complex items and so is usually sequenced a syllabus modelled on the basis of structural /grammatical content. Teaching methods that highly emphasise on form / grammar such as the Grammar Translation Method (GTM) and the Audiolingual Method (ALM) both determine and are best supported by such curricula. • Functional-notional orientation Syllabi‚ which focus on what the learner needs to do with the language. The language content and the emphasis‚ therefore‚ are
Premium Language education Linguistics
Colgate Max Fresh’s (CMF) introduction to the US market drove Colgate-Palmolive’s (CP) US market’s value share up to 34.8% ahead from Procter & Gamble (P&G) at 2nd place with 31.6% value share. Nigel Burton‚ CP’s president for global oral care division is tasked to run the marketing of CMF in China and Mexico and is wondering if the product will generate enough sales to cover the costs of adapting CMF to the respective local markets. Burton also needs to check if there is a fit in terms of product
Premium
INTRODUCTION 1.0 BACKGROUND OF THE REPORT: The name of the topic is “Marketing of Pharmaceuticals product: A study on Beximco Pharmaceuticals Limited.” Medicine is directly related to human life and therefore‚ its manufacturers have immense social responsibility of providing safe and effective medicine‚ demanding uncompromising efforts‚ at all levels of its activities. Beximco pharmaceuticals Ltd the leading health care company in Bangladesh has been making every effort to ensure the effectiveness
Premium Marketing Marketing research Pharmaceutical industry
Maithani M et al. / Pharmacie Globale (IJCP) 2010‚ 5 (05) Available online at www.pharmacie-globale.info ISSN 0976-8157 Research Article PHARMACIE GLOBALE INTERNATIONAL JOURNAL OF COMPREHENSIVE PHARMACY DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR THE DETERMINATION OF CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE IN PHARMACEUTICAL DOSAGE FORM Mukesh Maithani*‚ Richa Raturi‚ Vertika Gautam‚ Dharmendra Kumar‚ Amrendra Kumar Chaudhary‚ Anand Gaurav and Ranjit Singh School of
Premium Analytical chemistry High performance liquid chromatography Chromatography
Managerial efficiency 4. Market entry 5. Diversification 6. Tax shields 7. Strategic Some unstated reasons for acquisitions: 1. Megalomania 2. Hubris spirit Forms of Business Combinations 1. Consolidation: result: a new firm e.g. Sandoz + Ciba Geigy = Novartis 2. Merger: result: only one survive e.g. HDFC BK + TIMES BK = HDFC 3. Takeovers: control over mgmt thru substantial portion of its equity. e.g. Credit Swiss Group controlled First Boston’s Mgmt thru Equity acquisition. Both remained in existence
Premium Takeover Mergers and acquisitions Stock
Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society. However‚ the need for innovative therapies for unmet needs /challenging diseases continues to grow‚ accelerating the pace of drug development directly or through partnership/ in-licensing. We expect innovation and improved drugs therapies through novel target discovery and technology platforms
Premium Drug discovery Clinical trial Orphan drug
Arthritis Care & Research Vol. 64‚ No. 4‚ April 2012‚ pp 465– 474 DOI 10.1002/acr.21596 © 2012‚ American College of Rheumatology SPECIAL ARTICLE American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand‚ Hip‚ and Knee MARC C. HOCHBERG‚1 ROY D. ALTMAN‚2 KARINE TOUPIN APRIL‚3 MARIA BENKHALTI‚3 GORDON GUYATT‚4 JESSIE MCGOWAN‚3 TANVEER TOWHEED‚5 VIVIAN WELCH‚3 GEORGE WELLS‚3 AND PETER TUGWELL3 Guidelines and recommendations
Premium Evidence-based medicine Osteoarthritis
Teva Pharmaceuticals Strategy Overview 4/22/2013 PARTHIBAN SELVAM SMU MBA 2013 Business Overview: Teva Pharmaceuticals is a pharmaceutical company specializing in generic and proprietary drugs. It is the world’s 11th biggest pharmaceutical company. Apart from its major market‚ US and Europe‚ it has a major presence in Russia‚ Latin America‚ Japan and South Korea. In 2012‚ it had revenue of 20.3 billion and a net income of 1.96 billion (see table 1). Target Customers: Teva pharmaceutical’s
Premium Generic drug Pharmaceutical industry Pharmacology